Cargando…

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry

AIMS: Renal denervation has been shown to lower blood pressure in sham-controlled trials and represents a device-based treatment option for hypertension. We sought to project clinical event reductions after radiofrequency renal denervation using a novel modelling approach. METHODS AND RESULTS: The G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmieder, Roland E, Mahfoud, Felix, Mancia, Giuseppe, Narkiewicz, Krzysztof, Ruilope, Luis, Hutton, David W, Cao, Khoa N, Hettrick, Douglas A, Fahy, Martin, Schlaich, Markus P, Böhm, Michael, Pietzsch, Jan B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495746/ https://www.ncbi.nlm.nih.gov/pubmed/36057838 http://dx.doi.org/10.1093/ehjqcco/qcac056

Ejemplares similares

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)

Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014)

Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
por: Fadl Elmula, Fadl Elmula M., et al.
Publicado: (2015)

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
por: Sharp, Andrew S.P., et al.
Publicado: (2022)

Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria
por: Schönherr, Elisabeth, et al.
Publicado: (2016)

Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
por: Böhm, Michael, et al.
Publicado: (2017)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome
por: Selejan, Simina-Ramona, et al.
Publicado: (2022)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Renal denervation in hypertensive patients not on blood pressure lowering drugs
por: De Jager, Rosa L., et al.
Publicado: (2016)

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial
por: Weber, Thomas, et al.
Publicado: (2022)

Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
por: Ruilope, Luis Miguel, et al.
Publicado: (2007)

SYMPLICITY HTN-3 results to be announced: a mystery or a story foretold?
por: Staessen, Jan A, et al.
Publicado: (2014)

Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
por: Honarvar, Mehrdad, et al.
Publicado: (2013)

Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model
por: Wolf, Milan, et al.
Publicado: (2018)

Renal Denervation in Daily Practice: If So, How?
por: Millenaar, Dominic, et al.
Publicado: (2020)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study
por: Mahfoud, Felix, et al.
Publicado: (2013)

Adherence to antihypertensive medication in renal denervation trials: new studies, old problems?
por: Lauder, Lucas, et al.
Publicado: (2023)

Reduction in Basal Nitric Oxide Activity Causes Albuminuria
por: Ott, Christian, et al.
Publicado: (2011)

Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats
por: Hohl, Mathias, et al.
Publicado: (2016)

Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update
por: Borghi, Claudio, et al.
Publicado: (2019)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry
por: Zweiker, David, et al.
Publicado: (2016)

The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study
por: Schmieder, Roland E., et al.
Publicado: (2016)

Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial
por: Stoiber, Lukas, et al.
Publicado: (2018)

Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH)
por: Moss, Jonathan G., et al.
Publicado: (2016)

Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation
por: Schmieder, Roland E., et al.
Publicado: (2016)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
por: Gitt, Anselm K, et al.
Publicado: (2013)

Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
por: Gitt, Anselm K., et al.
Publicado: (2016)

Multi-organ denervation: a novel approach to combat cardiometabolic disease
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8raiarlalmhci0sd6ov7f674h2